Cargando…
Designing tuberculosis vaccine efficacy trials – lessons from recent studies
Introduction: Tuberculosis (TB) is the leading infectious killer globally and new TB vaccines will be crucial to ending the epidemic. Since the introduction in 1921 of the only currently licensed TB vaccine, BCG, very few novel vaccine candidates or strategies have advanced into clinical efficacy tr...
Autor principal: | Ginsberg, Ann M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6492041/ https://www.ncbi.nlm.nih.gov/pubmed/30892969 http://dx.doi.org/10.1080/14760584.2019.1593143 |
Ejemplares similares
-
Mandatory COVID-19 Vaccination: Lessons from Tuberculosis and HIV
por: Mtimkulu-Eyde, Lynette, et al.
Publicado: (2022) -
Recent Lessons Learned From Prevention and Recent-Onset Type 1 Diabetes Immunotherapy Trials
por: Staeva, Teodora P., et al.
Publicado: (2013) -
Failure by design: lessons from the recently rescinded light brown apple moth (
Epiphyas postvittana
) eradication program in California
por: Carey, James R., et al.
Publicado: (2022) -
Pharmacovigilance and tuberculosis: applying the lessons of thioacetazone
por: Falzon, Dennis, et al.
Publicado: (2014) -
Real-Time Operational Research: Case Studies from the Field of Tuberculosis and Lessons Learnt
por: Harries, Anthony D., et al.
Publicado: (2021)